BIOPROGNOSTIC

Welcome to the Brand page for “BIOPROGNOSTIC”, which is offered here for Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in kidney, heart, and liver health testing and disease prediction;bio prognostic;.

Its status is currently believed to be active. Its class is unavailable. “BIOPROGNOSTIC” is believed to be currently owned by “Renalytix AI, Inc.”